Journal article Open Access

ACVR1 and TGFBR1 purification, and composite screen design

Adamson, Roslin; Brennan, Paul; Mateucci, Mizio; Bullock, Alex

Purification of ACVR1 as well as TGFBR1, and design of a super screen for ACVR1

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].
Files (9.9 MB)
Name Size
Design of mega screen for ACVR1.docx
md5:d6facd546a4d7af2bad55fbf2ff8ea24
20.3 kB Download
Purification of ACVR1 for co_crystallisation with M4K compounds_Sep_2018.docx
md5:9050a9630936aaa69e8f6fce3dbb4761
8.8 MB Download
Purification of TGFBR1 for co_crystallisation with M4K compounds.docx
md5:fec99fbc319b25a8ce5304043813c533
1.1 MB Download
176
79
views
downloads
All versions This version
Views 176176
Downloads 7979
Data volume 233.7 MB233.7 MB
Unique views 150150
Unique downloads 3535

Share

Cite as